Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, CA
TAKEDA EXAMINE trial patients for who have Type II diabetes & ACS coronary artery disease, post angiogram or heart attack. This is a phase 3b study. Currently open for enrollment.
The purpose of this study is to evaluate the cardiovascular outcomes of alogliptin compared with placebo, in addition to standard of care, in patients with type II diabetes mellitus and acute coronary syndrome.
Patient Inclusion Criteria:
In order to participate in this study you need to have a hgA1c level between 6.5-11.0% , and a history of ACS (acute coronary syndrome) that required hospitalization with in 15-90 days prior to randomization.
Patient Exclusion Criteria:
CW ID: 181277
Date Last Changed:
July 18, 2013
Nasra Hashmi, Clinical Research SpecialistCoastal Multi-Specialty Research2621 S. Bristol St. Suite 108ASanta Ana, CA 92704Phone: 714-754-1684
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2017 CenterWatch.